Literature DB >> 21724716

Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Nicola Dalbeth1, Fiona M McQueen, Jasvinder A Singh, Patricia A MacDonald, N Lawrence Edwards, H Ralph Schumacher, Lee S Simon, Lisa K Stamp, Tuhina Neogi, Angelo L Gaffo, Puja P Khanna, Michael A Becker, William J Taylor.   

Abstract

Despite the recognition that tophus regression is an important outcome measure in clinical trials of chronic gout, there is no agreed upon method of tophus measurement. A number of methods have been used in clinical trials of chronic gout, from simple physical measurement techniques to more complex advanced imaging methods. This article summarizes methods of tophus measurement and discusses their properties. Physical measurement using Vernier calipers meets most aspects of the Outcome Measures in Rheumatology (OMERACT) filter. Rigorous testing of the complex methods, particularly with respect to reliability and sensitivity to change, is needed to determine the appropriate use of these methods. Further information is also required regarding which method of physical measurement is best for use in future clinical trials. The need to develop and test a patient-reported outcome measure of tophus burden is also highlighted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724716      PMCID: PMC3882031          DOI: 10.3899/jrheum.110272

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Magnetic resonance imaging in the quantitative assessment of gouty tophi.

Authors:  H R Schumacher; M A Becker; N L Edwards; W E Palmer; P A MacDonald; W Palo; N Joseph-Ridge
Journal:  Int J Clin Pract       Date:  2006-04       Impact factor: 2.503

2.  Computed tomography measurement of tophus volume: comparison with physical measurement.

Authors:  Nicola Dalbeth; Barnaby Clark; Kate Gregory; Gregory D Gamble; Anthony Doyle; Fiona M McQueen
Journal:  Arthritis Rheum       Date:  2007-04-15

3.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Authors:  Michael A Becker; H Ralph Schumacher; Robert L Wortmann; Patricia A MacDonald; Denise Eustace; William A Palo; Janet Streit; Nancy Joseph-Ridge
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 4.  Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide.

Authors:  Nicola Dalbeth; Cameron Schauer; Patricia Macdonald; Fernando Perez-Ruiz; H Ralph Schumacher; Steve Hamburger; Hyon K Choi; Fiona M McQueen; Anthony Doyle; William J Taylor
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

5.  Tophaceous joint disease strongly predicts hand function in patients with gout.

Authors:  N Dalbeth; J Collis; K Gregory; B Clark; E Robinson; F M McQueen
Journal:  Rheumatology (Oxford)       Date:  2007-11-03       Impact factor: 7.580

6.  Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.

Authors:  Fernando Perez-Ruiz; Marcelo Calabozo; Jose I Pijoan; Ana M Herrero-Beites; Ana Ruibal
Journal:  Arthritis Rheum       Date:  2002-08

7.  Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

Authors:  Michael A Becker; H Ralph Schumacher; Patricia A MacDonald; Eric Lloyd; Christopher Lademacher
Journal:  J Rheumatol       Date:  2009-03-13       Impact factor: 4.666

8.  Ultrasonographic measurement of tophi as an outcome measure for chronic gout.

Authors:  Fernando Perez-Ruiz; Iñaki Martin; Begoña Canteli
Journal:  J Rheumatol       Date:  2007-07-15       Impact factor: 4.666

9.  Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

Authors:  H Ralph Schumacher; Michael A Becker; Robert L Wortmann; Patricia A Macdonald; Barbara Hunt; Janet Streit; Christopher Lademacher; Nancy Joseph-Ridge
Journal:  Arthritis Rheum       Date:  2008-11-15

10.  A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.

Authors:  W J Taylor; H R Schumacher; H S B Baraf; P Chapman; L Stamp; M Doherty; F McQueen; N Dalbeth; N Schlesinger; D E Furst; J Vazquez-Mellado; J Vazquez Mellado; M A Becker; A Kavanaugh; W Louthrenoo; T Bardin; D Khanna; L S Simon; H Yamanaka; H K Choi; X Zeng; V Strand; R Grainger; D Clegg; J A Singh; C Diaz-Torne; M Boers; P Gow; V G Barskova
Journal:  Ann Rheum Dis       Date:  2007-11-29       Impact factor: 19.103

View more
  7 in total

1.  Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking.

Authors:  Dodji V Modjinou; Svetlana Krasnokutsky; Soterios Gyftopoulos; Virginia C Pike; Elaine Karis; Robert T Keenan; Kristen Lee; Daria B Crittenden; Jonathan Samuels; Michael H Pillinger
Journal:  Clin Rheumatol       Date:  2017-06-16       Impact factor: 2.980

Review 2.  Outcome measures in acute gout: a systematic literature review.

Authors:  Nicola Dalbeth; Cathy S Zhong; Rebecca Grainger; Dinesh Khanna; Puja P Khanna; Jasvinder A Singh; Fiona M McQueen; William J Taylor
Journal:  J Rheumatol       Date:  2013-12-15       Impact factor: 4.666

3.  OMERACT endorsement of measures of outcome for studies of acute gout.

Authors:  Jasvinder A Singh; William J Taylor; Nicola Dalbeth; Lee S Simon; John Sundy; Rebecca Grainger; Rieke Alten; Lyn March; Vibeke Strand; George Wells; Dinesh Khanna; Fiona McQueen; Naomi Schlesinger; Annelies Boonen; Maarten Boers; Kenneth G Saag; H Ralph Schumacher; N Lawrence Edwards
Journal:  J Rheumatol       Date:  2013-12-15       Impact factor: 4.666

Review 4.  Dual-energy computed tomography for gout diagnosis and management.

Authors:  Nicola Dalbeth; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

5.  Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study.

Authors:  Janitzia Vazquez-Mellado; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Everardo Alvarez-Hernández; Sergio García-Méndez; Virginia Pascual-Ramos; Marina Rull-Gabayet
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

6.  [Austrian 3e-recommendations for diagnosis and management of gout 2013].

Authors:  Judith Sautner; Johann Gruber; Manfred Herold; Jochen Zwerina; Burkhard F Leeb
Journal:  Wien Klin Wochenschr       Date:  2013-12-03       Impact factor: 1.704

7.  An optimal ultrasonographic diagnostic test for early gout: A prospective controlled study.

Authors:  Eleonora Norkuviene; Mykolas Petraitis; Indre Apanaviciene; Dalia Virviciute; Asta Baranauskaite
Journal:  J Int Med Res       Date:  2017-06-15       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.